Oscar Health (NYSE:OSCR) Stock Rating Lowered by Wall Street Zen

Oscar Health (NYSE:OSCR) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

A number of other analysts have also weighed in on OSCR. Piper Sandler lowered shares of Oscar Health from an “overweight” rating to a “neutral” rating and set a $14.00 price objective on the stock. in a research note on Monday, July 14th. Wells Fargo & Company lowered shares of Oscar Health from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Barclays cut their price objective on shares of Oscar Health from $17.00 to $11.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 23rd. UBS Group reiterated a “sell” rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Finally, Raymond James Financial lowered shares of Oscar Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, June 24th. Six investment analysts have rated the stock with a sell rating and four have given a hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce” and an average price target of $12.21.

Oscar Health Trading Up 1.8%

NYSE OSCR opened at $15.43 on Friday. The company has a fifty day simple moving average of $15.90 and a two-hundred day simple moving average of $14.86. The stock has a market cap of $3.93 billion, a P/E ratio of -19.05 and a beta of 1.86. Oscar Health has a 12-month low of $11.20 and a 12-month high of $23.79. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.90) by $0.01. The business had revenue of $2.86 billion during the quarter, compared to analysts’ expectations of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.75%. The business’s quarterly revenue was up 29.0% on a year-over-year basis. During the same quarter last year, the company posted $0.20 earnings per share. On average, analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

Insider Buying and Selling

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director directly owned 64,512 shares of the company’s stock, valued at $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 24.39% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Deerfield Management Company L.P. Series C increased its position in shares of Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after acquiring an additional 3,983,325 shares during the last quarter. Nuveen LLC acquired a new position in Oscar Health in the 1st quarter valued at $29,684,000. Gilder Gagnon Howe & Co. LLC grew its stake in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock worth $85,154,000 after purchasing an additional 2,151,256 shares during the period. Thrive Capital Management LLC grew its stake in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Finally, Man Group plc grew its stake in Oscar Health by 344.8% in the 4th quarter. Man Group plc now owns 1,813,216 shares of the company’s stock valued at $24,370,000 after acquiring an additional 1,405,554 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.